Amikacin: Clinical Trials

50 trials of Amikacin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 9 unknown, 7 recruiting, 3 terminated. 12 Phase 4, 11 Not applicable, 9 Phase 2, 4 Early Phase 1, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 8, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1
Not applicable11Completed 6, Recruiting 2, Unknown 2, Terminated 1
Phase 29Completed 4, Recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Early Phase 14Unknown 3, Terminated 1
Phase 13Completed 2, Enrolling by invitation 1
Phase 33Completed 2, Recruiting 1

Follow Amikacin: new trials by email Literature Review of Amikacin trials Research Report on Amikacin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
Amikacin, Standard of care - Pneumonia, Bacterial, Extracorporeal Membrane Oxygenation
Phase 2RecruitingAssistance Publique - Hôpitaux de Paris262026-08-102026-08-13
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer
Phase 4Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1362026-06-012026-05-15
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
Mycobacteriophage Muddy_HRMN0052, Amikacin Injection, Clofazimine - Non-Tuberculous Mycobacterial (NTM) Pneumonia, Mycobacterium Abscessus Infection
Phase 1Enrolling by invitationVancouver Coastal Health12026-01-112026-06-03
Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.
Colistimethate sodium for injection, meropenem, Amikacin Injection and meropenem - MDR Bacteria
Phase 4Active not recruitingBeni-Suef University1002025-12-302026-07-14
Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis
mannitol-enhanced aminoglycoside, Ceftriaxon, Amikacin - Urinary Tract Infections, Urological System Complication of Procedure
Early Phase 1UnknownCentre Hospitalier Universitaire Vaudois902024-01-162024-02-08
Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia
Amikacin (Inhalation), Standard-of-Care Intravenous Antibiotics - Ventilator Associated Pneumonia ( VAP)
Phase 4CompletedPostgraduate Medical Institute, Lahore902024-01-052026-01-27
the Incidence of Necrotizing Enterocolitis in Preterm With Respiratory Distress Syndrome Undergoing Caffeine Therapy
Caffeine citrate, Amikacin - Pharmacological Action of Drug
Early Phase 1UnknownAl-Azhar University502023-10-192023-10-24
Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
Amikacin - Tuberculosis, Multidrug-Resistant
Phase 2UnknownRwanda Biomedical Centre202023-03-012023-03-29
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Amikacin - Urinary Tract Infections
RecruitingAntonios Likourezos752022-09-212026-09-11
Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention
Intravesical aminoglycoside instillations - Urinary Tract Infections, Recurrent Urinary Tract Infection
CompletedLeiden University Medical Center442022-04-202023-03-08
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
Piperacillin and Tazobactam for Injection, Cefepime Injection, Ceftazidime Injection - Febrile Neutropenia
Phase 4CompletedMurdoch Childrens Research Institute552021-11-152026-03-20
Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center
extended meropenem infusion in combination with other options such as Polymyxin, Tigecycline, Ertapenem, or Amikacin., two β-lactam antibiotics plus a single non-β-lactam antibiotic, Control group received standard therapy - Ventilation Acquired Pneumonia
Phase 3CompletedBeni-Suef University642021-01-012024-12-18
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.
Cefuroxime, Amikacin - Sepsis, Septic Shock
UnknownRadboud University Medical Center402020-07-152022-09-10
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population
Treatment with Amikacin - Burn Patients
Phase 4TerminatedAssistance Publique Hopitaux De Marseille72020-01-062024-07-01
Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)
Fosfomycin Tromethamine 3G Sachet, Amikacin - Urinary Tract Infections, Bladder Cancer
Phase 2CompletedInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran752020-01-012023-04-04
Population Pharmacokinetics of Amikacin in Neonates
Amikacin Sulfate Injection - Neonatal Sepsis, Late-Onset
CompletedPontificia Universidad Catolica de Chile1382019-12-012022-04-07
Fixed-dose Amikacin for Elderly UTI
Amikacin - Urinary Tract Infections, Elderly Infection
Phase 4UnknownRabin Medical Center2002019-12-012019-12-13
Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Piperacillin/tazobactam, Meropenem, Daptomycin - Therapeutic Drug Monitoring, Subarachnoid Hemorrhage
UnknownAzienda Sanitaria-Universitaria Integrata di Udine1042019-10-012021-07-21

Showing 20 of 50. Sign in to see all of them.

Conditions studied

Urinary Tract Infections (7)  ·  Infections (5)  ·  Pneumonia, Ventilator-Associated (5)  ·  Pneumonia (4)  ·  Sepsis (4)  ·  Febrile Neutropenia (3)  ·  HIV Infections (3)  ·  Lung Diseases (3)  ·  Mycobacterium Infections, Nontuberculous (3)  ·  Neoplasms (3)  ·  Neutropenia (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Bacterial Infections (2)  ·  Cystic Fibrosis (2)  ·  Healthcare-Associated Pneumonia (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beni-Suef University (2)  ·  The University of Queensland (2)  ·  Al-Azhar University (1)  ·  Antonios Likourezos (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Azienda Sanitaria-Universitaria Integrata di Udine (1)  ·  Bayer (1)  ·  Beijing Children's Hospital (1)  ·  Cardeas Pharma (1)  ·  Centre Hospitalier Intercommunal Creteil (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)

Countries

United States (10)  ·  France (8)  ·  Egypt (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  Argentina (2)  ·  Australia (2)  ·  Belgium (2)  ·  Canada (2)  ·  China (2)  ·  India (2)  ·  Israel (2)  ·  Singapore (2)  ·  Spain (2)  ·  Thailand (2)

Top investigators

A-Dong Shen, Master (1)  ·  Annick de Jaeger, MD (1)  ·  Anthony J Schaeffer, MD (1)  ·  Benson C (1)  ·  Chee Fui Chong, FRCSEd (1)  ·  Chi Hornik, PharmD (1)  ·  Chirgwin K (1)  ·  DM Parenti (1)  ·  David Seligson, MD (1)  ·  Florian Thalhammer, Prof. Dr. (1)  ·  Gabrielle Haeusler (1)  ·  J Ellner (1)

Results publications

PMID 15276398, PMID 15840453, PMID 16470119, PMID 16988514, PMID 18366444, PMID 18570578, PMID 18752007, PMID 18795962, PMID 18989231, PMID 19588358, PMID 19698010, PMID 20002783, PMID 20632458, PMID 21283017, PMID 22083071, PMID 22129166, PMID 22147112, PMID 22530208, PMID 23305215, PMID 23392467, PMID 24614374, PMID 24903189, PMID 24949994, PMID 25084971, PMID 25162818, PMID 25261418, PMID 25327505, PMID 25407158, PMID 25950206, PMID 25959631, PMID 26039810, PMID 26202768, PMID 26429564, PMID 26918544, PMID 26926644, PMID 27522443, PMID 27540363, PMID 28137820, PMID 28290120, PMID 28592230, PMID 28779462, PMID 29084742, PMID 29180278, PMID 29271816, PMID 29369162, PMID 29435949, PMID 29520730, PMID 29528944, PMID 29677389, PMID 30134297

NIH funding

2015 (1)